Clinical Trial Update: Safety and Efficacy of an Antioxidant-rich Multivitamin Supplement in Cystic Fibrosis [Phase 1, Phase 2]

View source ↗

Summary

A phase 1/2 clinical trial evaluating the safety and potential efficacy of an antioxidant-rich multivitamin supplement in cystic fibrosis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystic Fibrosis

Drugs mentioned

• Antioxidant-rich multivitamin supplement

Snippet

Sponsor: University of Colorado, Denver | Conditions: Cystic Fibrosis | Phase 1, Phase 2 | Status: COMPLETED